drugset / Trial / NCT04609670
Study of Radiolabeled ALXN2050 in Healthy Adult Males
NaSingle-groupOpen-labelBasic science
Summary
This is an open-label study to assess the absorption, metabolism, excretion, and mass balance of a single oral dose of carbon-14 (\[14C\])-ALXN2050 in healthy adult males.
Timeline
- Start
- 2021-04-12
- Primary completion
- 2021-08-23
- Completion
- 2021-08-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vemircopan | Small molecule | 200 mg | Oral |
Indications
No indication recorded.